TY  - JOUR
AU  - Taieb, Julien
AU  - Rivera, Fernando
AU  - Siena, Salvatore
AU  - Karthaus, Meinolf
AU  - Valladares-Ayerbes, Manuel
AU  - Gallego, Javier
AU  - Geissler, Michael
AU  - Koukakis, Reija
AU  - Demonty, Gaston
AU  - Peeters, Marc
PY  - 2017
DO  - 10.1007/s00432-017-2534-z
UR  - http://hdl.handle.net/10668/11743
T2  - Journal of cancer research and clinical oncology
AB  - To report exploratory analyses of early tumour shrinkage (ETS) and depth of response (DpR) in patients with RAS wild-type (WT) metastatic colorectal cancer (mCRC), receiving the first-line treatment in three randomised panitumumab trials. Data from...
LA  - en
KW  - Depth of response
KW  - Early tumour shrinkage
KW  - Metastatic colorectal cancer
KW  - Panitumumab
KW  - Survival
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antibodies, Monoclonal
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Colorectal Neoplasms
KW  - Female
KW  - Fluorouracil
KW  - GTP Phosphohydrolases
KW  - Humans
KW  - Leucovorin
KW  - Male
KW  - Membrane Proteins
KW  - Middle Aged
KW  - Organoplatinum Compounds
KW  - Panitumumab
KW  - Proto-Oncogene Proteins B-raf
KW  - Proto-Oncogene Proteins p21(ras)
KW  - Treatment Outcome
KW  - Young Adult
TI  - Exploratory analyses assessing the impact of early tumour shrinkage and depth of response on survival outcomes in patients with RAS wild-type metastatic colorectal cancer receiving treatment in three randomised panitumumab trials.
TY  - research article
VL  - 144
ER  -